|
MRI News Service:
'Food and Drug Administration' p6 |
|
| Result: Searchterm 'Food and Drug Administration' found in 75 news | | Result Pages | | More Results:  Database (9) |
|
|
 |
 | | | '''''Bayer HealthCare Pharmaceuticals announced today that the U.S. Food and Drug Administration has approved Bayer's gadobutrol injection Gadavistâ„¢ (gadobutrol), a 1.0 molar macrocyclic gadolinium-based contrast agent (GBCA) for intravenous use in ...' | | Tuesday, 15 March 2011 by viva.vita.bayerhealthcare.de |
|
|
|
| | | '''''Medtronic, Inc. (NYSE:MDT - News) today announced that the U.S. Food and Drug Administration (FDA) approved its Revo MRI™ SureScan® pacing system, the first and only pacemaker in the U.S. specifically designed for use in an Magnetic Resonance Imaging ...' | | | Tuesday, 8 February 2011 by www.biospace.com | |
|
|
|
| | | '''''Bayer HealthCare Pharmaceuticals Inc. announced today that the Peripheral and Central Nervous System Drugs Advisory Committee to the U.S. Food and Drug Administration (FDA) voted unanimously that clinical trial and postmarketing data for gadobutrol ...' | | | Friday, 21 January 2011 by www.biospace.com | |
|
|
|
| | | '''''Covidien (NYSE:COV), a leading global provider of healthcare products, today announced it supports the U.S. Food and Drug Administration's (FDA) labeling changes for gadolinium-based contrast agents for patients with acute kidney injury or chronic, ...' | | | Friday, 10 September 2010 by investor.covidien.com | |
|
|
|
| | | ''''' Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, supports the U.S. Food and Drug Administration's (FDA) announcement requiring safety-related label changes for all gadolinium-based contrast agents to highlight the rare ...' | | | Friday, 10 September 2010 by www.radiopharm.com | |
|
|
|
| | | '''''The U.S. Food and Drug Administration is requiring that gadolinium-based contrast agents (GBCAs) carry new warnings on their labels about the risk of a rare and potentially fatal condition known as nephrogenic systemic fibrosis (NSF), if the drug is ...' | | | Thursday, 9 September 2010 by www.fda.gov | |
|
|
|
| | | '''''Bayer Schering Pharma AG, Berlin, Germany, announced today that the Food and Drug Administration (FDA) has accepted for filing a New Drug Application to the U.S. for gadobutrol injection, a gadolinium-based contrast agent for magnetic resonance ...' | | | Friday, 6 August 2010 by www.medicalnewstoday.com | |
|
|
|
| | | '''''Bayer Schering Pharma AG, Berlin, Germany, announced today that the Food and Drug Administration (FDA) has accepted for filing a New Drug Application to the U.S. for gadobutrol injection, a gadolinium-based contrast agent for magnetic resonance ...' | | | Wednesday, 4 August 2010 by viva.vita.bayerhealthcare.de | |
|
|
|
| | | '''''New recommendations to protect participant safety in clinical trials of certain Alzheimer's disease drugs have been accepted by the U.S. Food and Drug Administration (FDA) and are already being incorporated into research studies. These safety ...' | | | Monday, 12 July 2010 by www.prnewswire.com | |
|
|
|
| | | '''''Medtronic Inc. (MDT - Analyst Report) has received several complaints from the U.S. Food and Drug Administration (FDA) regarding the company's study of a new pacemaker that can be used in a Magnetic Resonance Imaging (MRI) machine. The FDA has raised ...' | | | Wednesday, 17 March 2010 by www.zacks.com | |
|
|
|
|
|
|
|
|
| Result Pages |
|
|
|
|
|
Age is not a particularly interesting subject. Anyone can get old. All you
have to do is live long enough.
- Groucho Marx |
|
|
News
top
